Does CAPLACIZUMAB Cause Foetal growth restriction? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Foetal growth restriction have been filed in association with CAPLACIZUMAB (Cablivi). This represents 6.2% of all adverse event reports for CAPLACIZUMAB.
9
Reports of Foetal growth restriction with CAPLACIZUMAB
6.2%
of all CAPLACIZUMAB reports
4
Deaths
0
Hospitalizations
How Dangerous Is Foetal growth restriction From CAPLACIZUMAB?
Of the 9 reports, 4 (44.4%) resulted in death.
Is Foetal growth restriction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPLACIZUMAB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does CAPLACIZUMAB Cause?
Off label use (26)
Condition aggravated (13)
Platelet count decreased (12)
Drug ineffective (10)
Maternal exposure during pregnancy (10)
Pyrexia (10)
Thrombotic thrombocytopenic purpura (10)
Foetal exposure during pregnancy (9)
Haemorrhage (9)
Deep vein thrombosis (8)
What Other Drugs Cause Foetal growth restriction?
ASPIRIN (414)
PREDNISOLONE (269)
PREDNISONE (222)
AZATHIOPRINE (200)
ENOXAPARIN (198)
TACROLIMUS (184)
HYDROXYCHLOROQUINE (178)
DEXAMETHASONE (172)
METHYLDOPA (172)
METHYLPREDNISOLONE (168)
Which CAPLACIZUMAB Alternatives Have Lower Foetal growth restriction Risk?
CAPLACIZUMAB vs CAPLACIZUMAB-YHDP
CAPLACIZUMAB vs CAPMATINIB
CAPLACIZUMAB vs CAPREOMYCIN
CAPLACIZUMAB vs CAPSAICIN
CAPLACIZUMAB vs CAPTOPRIL